IBT
ABMD

International Biotechnology Trust’s Abiomed Inc ABMD Stock Holding History

International Biotechnology Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,700
Closed -$2.08M – 65
2019
Q3 		$2.08M Hold
11,700
– – 0.96% 24
2019
Q2 		$3.05M Hold
11,700
– – 1.13% 24
2019
Q1 		$3.34M Hold
11,700
– – 1.23% 27
2018
Q4 		$2.99M Sell
11,700
-1,500
-11% -$521K 1.85% 20
2018
Q3 		$4.55M Hold
13,200
– – 2.16% 18
2018
Q2 		$5.4M Buy
+13,200
New +$4.78M 2.07% 19

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

International Biotechnology Trust's ABMD Position: Q4 2019 in Review

International Biotechnology Trust sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 11,700 shares — an estimated $2.08M sold.

International Biotechnology Trust first reported a position in ABMD in Q2 2018 and held it in 6 quarters. The position peaked at $5.4M in Q2 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • International Biotechnology Trust reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • International Biotechnology Trust sold 11,700 Abiomed Inc shares in Q4 2019, an estimated $2.08M.
  • International Biotechnology Trust first reported a position in Abiomed Inc in Q2 2018 and held it in 6 quarters.
  • International Biotechnology Trust's Abiomed Inc position peaked at $5.4M in Q2 2018.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on International Biotechnology Trust's 13F filing for Q4 2019, filed 18 May 2020.